RT Journal Article T1 Effect of COVID-19 on Thoracic Oncology Surgery in Spain: A Spanish Thoracic Surgery Society (SECT) Survey. A1 Martínez-Hernández, Néstor J A1 Caballero Silva, Usue A1 Cabañero Sánchez, Alberto A1 Campo-Cañaveral de la Cruz, José Luis A1 Obeso Carillo, Andrés A1 Jarabo Sarceda, José Ramón A1 Sevilla López, Sebastián A1 Cilleruelo Ramos, Ángel A1 Recuero Díaz, José Luis A1 Call, Sergi A1 Couñago, Felipe A1 Hernando Trancho, Florentino A1 On Behalf Of The Scientific Committee Of The Spanish Thoracic Surgery Society, K1 COVID-19 K1 lung cancer K1 surgical treatment AB After the first wave of COVID-19, the Spanish Society of Thoracic Surgeons (SECT) surveyed its members to assess the impact of the pandemic on thoracic oncology surgery in Spain. In May 2020, all SECT members were invited to complete an online, 40-item, multiple choice questionnaire. The questionnaire was developed by the SECT Scientific Committee and sent via email. The overall response rate was 19.2%. The respondents answered at least 91.5% of the items, with only one exception (a question about residents). Most respondents (89.3%) worked in public hospitals. The reported impact of the pandemic on routine clinical activity was considered extreme or severe by 75.5% of respondents (25.5% and 50%, respectively). Multidisciplinary tumour boards were held either with fewer members attending or through electronic platforms (44.6% and 35.9%, respectively). Surgical activity decreased by 95.7%, with 41.5% of centers performing surgery only on oncological patients and 11.7% only in emergencies. Nearly 60% of respondents reported modifying standard protocols for early-stage cancer and in the preoperative workup. Most centers (≈80%) reported using full personal protective equipment when operating on COVID-19 positive patients. The COVID-19 pandemic severely affected thoracic oncology surgery in Spain. The lack of common protocols led to a variable care delivery to lung cancer patients. SN 2072-6694 YR 2021 FD 2021-06-09 LK http://hdl.handle.net/10668/18116 UL http://hdl.handle.net/10668/18116 LA en DS RISalud RD Apr 7, 2025